Global cancer statistics, 2012

Published on Mar 1, 2015in CA: A Cancer Journal for Clinicians292.278
· DOI :10.3322/CAAC.21262
Lindsey A. Torre16
Estimated H-index: 16
(ACS: American Cancer Society),
Freddie Bray119
Estimated H-index: 119
(IARC: International Agency for Research on Cancer)
+ 3 AuthorsAhmedin Jemal139
Estimated H-index: 139
(ACS: American Cancer Society)
Cancer constitutes an enormous burden on society in more and less economically developed countries alike. The occurrence of cancer is increasing because of the growth and aging of the population, as well as an increasing prevalence of established risk factors such as smoking, overweight, physical inactivity, and changing reproductive patterns associated with urbanization and economic development. Based on GLOBOCAN estimates, about 14.1 million new cancer cases and 8.2 million deaths occurred in 2012 worldwide. Over the years, the burden has shifted to less developed countries, which currently account for about 57% of cases and 65% of cancer deaths worldwide. Lung cancer is the leading cause of cancer death among males in both more and less developed countries, and has surpassed breast cancer as the leading cause of cancer death among females in more developed countries; breast cancer remains the leading cause of cancer death among females in less developed countries. Other leading causes of cancer death in more developed countries include colorectal cancer among males and females and prostate cancer among males. In less developed countries, liver and stomach cancer among males and cervical cancer among females are also leading causes of cancer death. Although incidence rates for all cancers combined are nearly twice as high in more developed than in less developed countries in both males and females, mortality rates are only 8% to 15% higher in more developed countries. This disparity reflects regional differences in the mix of cancers, which is affected by risk factors and detection practices, and/or the availability of treatment. Risk factors associated with the leading causes of cancer death include tobacco use (lung, colorectal, stomach, and liver cancer), overweight/obesity and physical inactivity (breast and colorectal cancer), and infection (liver, stomach, and cervical cancer). A substantial portion of cancer cases and deaths could be prevented by broadly applying effective prevention measures, such as tobacco control, vaccination, and the use of early detection tests. CA Cancer J Clin 2015;65: 87–108. © 2015 American Cancer Society.
Figures & Tables
📖 Papers frequently viewed together
1 Author (David P. Bartel)
27.7k Citations
18.7k Citations
18.1k Citations
#1Jacques Ferlay (IARC: International Agency for Research on Cancer)H-Index: 77
#2Isabelle Soerjomataram (IARC: International Agency for Research on Cancer)H-Index: 50
Last. Freddie Bray (IARC: International Agency for Research on Cancer)H-Index: 119
view all 9 authors...
Estimates of the worldwide incidence and mortality from 27 major cancers and for all cancers combined for 2012 are now available in the GLOBOCAN series of the International Agency for Research on Cancer. We review the sources and methods used in compiling the national cancer incidence and mortality estimates, and briefly describe the key results by cancer site and in 20 large “areas” of the world. Overall, there were 14.1 million new cases and 8.2 million deaths in 2012. The most commonly diagno...
18.7k CitationsSource
#1Martyn Plummer (IARC: International Agency for Research on Cancer)H-Index: 52
#2Silvia Franceschi (IARC: International Agency for Research on Cancer)H-Index: 183
Last. Catherine de Martel (IARC: International Agency for Research on Cancer)H-Index: 15
view all 5 authors...
We previously estimated that 660,000 cases of cancer in the year 2008 were attributable to the bacterium Helicobacter pylori (H. pylori), corresponding to 5.2% of the 12.7 million total cancer cases that occurred worldwide. In recent years, evidence has accumulated that immunoblot (western blot) is more sensitive for detection of anti-H. pylori antibodies than ELISA, the detection method used in our previous analysis. The purpose of this short report is to update the attributable fraction (AF) e...
407 CitationsSource
#1F Reddy S ItasH-Index: 1
#2V Alerie B EralH-Index: 1
Last. R Obin W EissH-Index: 1
view all 9 authors...
4 Citations
#1A. AploganH-Index: 2
#2V. MangindulaH-Index: 2
Last. Herpesvirus BrH-Index: 1
view all 5 authors...
these, 304 (73%) met the probable case definition, and 115 (27%) were considered possible monkeypox cases. Most (85%) cases occurred in persons aged ,16 years. Nineteen persons had active disease. Preliminary testing of lesional material identified MPV in nine cases and varicella zoster virus in four. Of the 344 cases in the Katako-Kombe Health Zone, five persons died (case fatality ratio: 1.5%) within 3 weeks of rash onset; decedents ranged in age from 4 to 8 years. All 339 surviving case-patie...
78 Citations
#1Roman GulatiH-Index: 34
#2Alexander TsodikovH-Index: 51
Last. Matthew R. CooperbergH-Index: 74
view all 7 authors...
© 2014 American Cancer Society. BACKGROUND: Prostate-specific antigen (PSA) screening for prostate cancer has high risks of overdiagnosis, particularly among older men, and reports from screening trials indicate that it saves few lives after 11 to 13 years of follow-up. New clinical guidelines recommend against PSA screening for all men or for men aged >70 years, but, to the authors' knowledge, the expected population effects of these guidelines have not been studied to date. METHODS: Two models...
68 CitationsSource
#1John M Lacy (UK: University of Kentucky)H-Index: 5
#2Natasha Kyprianou (UK: University of Kentucky)H-Index: 60
The use of 5α-reductase inhibitors (5α-RIs) as prostate cancer chemoprevention agents is controversial. Two large randomized trials, the Prostate Cancer Prevention Trial (PCPT) and the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) Trial, have both shown a decreased incidence of prostate cancer in patients administered with 5α-RIs. Both studies showed, however, an increased risk of higher-grade prostate cancer. Numerous studies have since analyzed the inherent biases in these landma...
15 CitationsSource
#1Jack Cuzick (QMUL: Queen Mary University of London)H-Index: 147
#2Mangesh A. Thorat (QMUL: Queen Mary University of London)H-Index: 18
Last. Alicja Wolk (KI: Karolinska Institutet)H-Index: 151
view all 29 authors...
Prostate cancer is a common malignancy in men and the worldwide burden of this disease is rising. Lifestyle modifications such as smoking cessation, exercise, and weight control offer opportunities to reduce the risk of developing prostate cancer. Early detection of prostate cancer by prostate-specific antigen (PSA) screening is controversial, but changes in the PSA threshold, frequency of screening, and the use of other biomarkers have the potential to minimise the overdiagnosis associated with...
246 CitationsSource
#1Rolando Herrero (IARC: International Agency for Research on Cancer)H-Index: 114
#2Julie Parsonnet (Stanford University)H-Index: 67
Last. E.R. Greenberg (Fred Hutchinson Cancer Research Center)H-Index: 3
view all 3 authors...
72 CitationsSource
#1Liliane ChatenoudH-Index: 57
#2Paola BertuccioH-Index: 52
Last. C. La Vecchia (University of Milan)H-Index: 140
view all 7 authors...
among the elderly? J Epidemiol Community Health 2000; 54: 639–640. 30. Wodskou PM, Hundrup YA, Obel EB, Jorgensen T. Validity of self-reported birthweight among middle-aged and elderly women in the Danish Nurse Cohort Study. Acta Obstet Gynecol Scand 2010; 89: 1134–1139. 31. Patti ME. Intergenerational programming of metabolic disease: evidence from human populations and experimental animal models. Cell Mol Life Sci 2013; 70: 1597–1608.
85 CitationsSource
Purpose of the Review Provide an evidenced-based resource for the surveillance of gastrointestinal premalignant lesions, focusing on the scientific articles reported recently.
14 CitationsSource
Cited By18590
#1Zhe Li (UJN: University of Jinan)
#2Wendong Liu (UJN: University of Jinan)H-Index: 1
Last. Yizhong Lu (UJN: University of Jinan)H-Index: 30
view all 9 authors...
Abstract null null The concentrations of D-Proline (D-Pro) and D-Alanine (D-Ala) in the saliva of early-stage gastric cancer patients are prominently higher than those of healthy people. Therefore, precisely monitoring the concentrations of D-Pro and D-Ala has essential implications for gastric cancer diagnosis and treatment. Here, through pyrolysis of ZIF-8 precursor filled with glucose (G@ZIF-8), the carbon dots confined in N-doped carbon (CDs@NC) are successfully obtained. The CDs@NC can read...
1 CitationsSource
#3Serge Muller (GE Healthcare)H-Index: 8
Last. Kathleen M. SchmelerH-Index: 22
view all 3 authors...
#1Xinchun Zhou (UMMC: University of Mississippi Medical Center)H-Index: 18
#2Jinghe Mao (Tougaloo College)H-Index: 8
Last. Timothy Craig Allen (UMMC: University of Mississippi Medical Center)H-Index: 5
view all 8 authors...
Abstract null null Background null It remains under-investigated whether prostatic lipid profiles are associated with pathogenesis, progression, racial disparity, and discovery of biomarkers in prostate cancer (PCa). null null null Methods null The electrospray ionization-tandem mass spectrometry was applied to quantitate prostatic lipids in human and mouse PCa and non-cancer prostatic tissues. Biostatistics and bioinformatics were used to compare the concentrations of prostatic lipids at levels...
#1Guoyu Ma (TJU: Tianjin University)
#2Siyang Zuo (TJU: Tianjin University)H-Index: 8
Last. Jianbin Liu (TJU: Tianjin University)H-Index: 13
view all 3 authors...
#1Dong WangH-Index: 9
#2Tingting WangH-Index: 1
Last. Jun LiH-Index: 4
view all 9 authors...
Chemoresistance often occurs during 5-fluorouracil (5-Fu) treatment of colorectal cancer (CRC). It is significant to explore the potential strategies to sensitize colorectal cancer cells to 5-Fu treatment. We studied the sensitization of Nephroblastoma overexpressed protein (NOV) on 5-Fu treatment. NOV was overexpressed and knocked down in HT115 and RKO cells respectively. Cell proliferation experiments and related mechanism studies by RT-qPCR and Western blot were performed Subsequently. Nude m...
1 CitationsSource
#1Henry A. Adeola (UCT: University of Cape Town)H-Index: 7
#2Saheed Sabiu (Durban University of Technology)H-Index: 8
Last. Babatunji Emmanuel Oyinloye (Afe Babalola University)H-Index: 16
view all 7 authors...
Orthodox dentistry has undergone significant changes in recent times with the introduction of various omics and molecular targeted therapies both at the experimental/trial and clinical implementation level. Although, significant milestones have been achieved in the molecular dentistry field in the past decade, there remains a dearth of application of phytopharmacological innovation in personalized and targeted therapies for dental diseases. From time immemorial, plant products have long been an ...
#1Alaa Adnan Rashad (SVU: South Valley University)H-Index: 3
#2Mohamed BadawyH-Index: 2
Last. Mohamed Abdel-Bary (SVU: South Valley University)H-Index: 1
view all 5 authors...
Malignant endobronchial obstruction (MEBO) is the most debilitating complication in non-small cell lung cancer (NSCLC). The therapeutic role of cryotherapy and its impact on survival has not been well addressed. This is to clarify whether the combination of endobronchial cryotherapy (EBCT) and chemoradiotherapy (CRT) improved symptoms, respiratory functions, performance status, and survival outcomes in inoperable NSCLC with symptomatic MEBO compared to that obtained by CRT alone. A prospective c...
#1Davut Ibrahim Mahcicek (Boğaziçi University)
#2Korel D. Yildirim (NIH: National Institutes of Health)
Last. Ozgur Kocaturk (NIH: National Institutes of Health)H-Index: 19
view all 4 authors...